Navigation Links
Vermillion Announces Positive Top-Line Results from the OVA500 Multi-Center Study Led by UC Irvine
Date:7/30/2012

AUSTIN, Texas, July 30, 2012 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a leading molecular diagnostics company, today announced positive results from a new prospective, multi-center clinical study of its ovarian cancer diagnostic OVA1®. The study, referred to as OVA500, was led by Dr. Robert E. Bristow, director of Gynecologic Oncology Services at UC Irvine Healthcare in Orange, CA, and deputy editor of the journal Gynecologic Oncology.

OVA1 is a blood test for pre-surgical assessment of ovarian tumors for malignancy using a unique multi-biomarker approach. As the first protein-based, in vitro diagnostic multivariate index assay cleared by the U.S. Food and Drug Administration, OVA1 represents a new class of software-based diagnostics.

The OVA500 study confirms and extends the pioneering work of Dr. Fred Ueland published last year. It was a prospective, multi-institutional, blinded study with a new cohort of 494 patients representing the intended use population for OVA1: female patients who were scheduled to undergo surgery for an adnexal mass, enrolled from non gynecologic oncology practices via 27 study coordination centers.

All adnexal tumor types were included in the statistical analysis of test performance. The primary objective was to assess the performance of OVA1 in the intended use population with a focus on two particularly challenging subgroups: women with early-stage ovarian cancer, where approximately half of patients have a normal CA125 level, and pre-menopausal women, where the incidence of ovarian cancer is low and incidence of benign cysts is high.

Top-line data from the study are as follows:

Overall Performance of OVA1

  • Negative predictive value was reported at 98%
  • Sensitivity was reported at 96%
  • Specificity was reported at 51%

Performance in the Pre-menopausal Population


    '/>"/>

SOURCE Vermillion, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Vermillion PAD Intended Use Study Presented at Society for Vascular Medicine 23rd Annual Scientific Sessions
2. Vermillion Announces CEO Succession Plan
3. Vermillion Sets First Quarter 2012 Conference Call for Tuesday, May 15, 2012 at 4:30 p.m. ET
4. Insmed Announces Planned Departure Of Chief Financial Officer
5. Absorption Systems announces novel test platform for interactions with the BCRP transporter
6. Novogen Announces Merger Agreement With Kai Medical And Distribution Of Mei Pharma Shares
7. Aethlon Medical Announces the Appointment of Thomas V. Wornham and Philip A. Ward to its Board of Directors
8. IRIDEX Announces Second Quarter 2012 Conference Call and Release Date
9. Gentris Corporation Announces Collaboration to Study Blood Stability
10. RoundTable Healthcare Partners Announces Sale of Aspen Surgical Products Holding, Inc. to Hill-Rom Holdings, Inc.
11. Biomet Announces Pricing of Senior Notes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... and BOSTON , January 23, ... drug discovery and development company, is delighted to announce that ... been awarded to Miles Congreve (Vice President of ... and Malcolm Weir (Chief Executive Officer and co-founder) ...
(Date:1/22/2015)... Jan. 22, 2015  ResMed Inc. (NYSE: RMD ) ... Revenue for the quarter was $423.0 million, a 10 percent ... 14 percent increase on a constant currency basis). Net income ... the quarter ended December 31, 2013. Diluted earnings per share ...
(Date:1/22/2015)... 2015 Increasing sophistication among enterprise buyers of language ... in 2015, says Moravia CMO, Renato ... by market research firm Common Sense Advisory, 15 percent ... translation and localization needs. "From a language industry perspective, ...
Breaking Medicine Technology:Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 2ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 3ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 5ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 6ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 7ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 8ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 9ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 10ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 11Moravia Sees Single-Sourcing as Key Localization Trend in 2015 2
... NxStage® Medical, Inc. (Nasdaq: NXTM ) ... together with its patients and their care partners is ... and enthusiasm, NxStageUsers, together with thousands of other patients, ... to change the dialysis treatment paradigm and give dialysis ...
... SUNRISE, Fla., Oct. 5, 2011 Actavis Group CEO ... Latin America, among the world,s fastest-growing markets for generic ... at a meeting in South Florida with Actavis, new ... in Sunrise, Florida, will target Brazil, Argentina, Colombia, Mexico, ...
Cached Medicine Technology:NxStage Says 'Thank You' to Patients and Care Partners at the 2nd Annual NxStageUsers Meet-Up and Conference in New Orleans 2NxStage Says 'Thank You' to Patients and Care Partners at the 2nd Annual NxStageUsers Meet-Up and Conference in New Orleans 3Actavis Plans Latin America Expansion 2
(Date:1/22/2015)... Four years since the release of their debut ... the marriage of Avasa & Matthew Love – the duo are ... for release through White Swan Records on February 24, 2015. , ... sacred path available to all of us to walk out of ...
(Date:1/22/2015)... EBSCO Information Services (EBSCO) and ... relationship in an effort to further promote visibility and adoption ... has long made AMA journals available via its subscription services, ... JAMA Network. , Long known as both a ...
(Date:1/22/2015)... JJsHouse.com is a famous dress online store for ... its latest collection of wedding dresses , and launches ... is the wedding dress on your big day; the wedding ... Every bride wants to find the most suitable wedding dress. ...
(Date:1/22/2015)... Lower-Auto-Insurance.com has released a new blog post explaining ... for reducing the costs of an auto insurance policy . ... to get lower prices for their vehicle insurance policies. The safety ... determining policy costs. Because of this, drivers should always carry ...
(Date:1/22/2015)... USA (PRWEB) January 22, 2015 State ... statewide data management system with support from GEOSYSTEMS, a ... The new solution will leverage Hexagon Geospatial’s ERDAS ... vector data as well as point clouds and documents. ...
Breaking Medicine News(10 mins):Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2Health News:Driving Safe And Other Factors That Make Auto Insurance Affordable! 2Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 2Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 3
... & Johnson,Pharmaceutical Research & Development, L.L.C. announced that ... the U.S. Food and Drug,Administration (FDA) for tapentadol ... for the relief of moderate to,severe acute pain., ... than 25 million,Americans experience acute pain each year ...
... interdisciplinary team reports the design of chimeric ... for potential application in biomedical research. , ... stage where domains that traditionally belonged to ... are coming together to offer new synergistic ...
... made some women opt out of screening mammographies, study finds, ... small as $10 can stand in the way of a ... When women in Medicare managed-care plans were asked to contribute ... 8 percent of the women decided to forgo mammograms altogether, ...
... Procedure brings clot-busting drugs right to site of blood ... -- Therapies that attack blood clots directly in the ... to the standard treatment using clot-busting drugs. , So ... presented Tuesday at the 20th annual International Symposium on ...
... have identified subtle genetic variations that predict the ... found that certain variants in the gene for ... other substances out of the brain compromise the ... and venlafaxine (Effexor). , The researchers said their ...
... Jan. 23 U.S. Environmental,Protection Agency Region 5 has ... Canton, Ohio, for a project to cut diesel emissions ... will be used to retrofit 24 school buses with,equipment ... two 1988,school buses with new, low-emission 2007 model year ...
Cached Medicine News:Health News:New Drug Application Submitted to FDA for Investigational Analgesic Tapentadol Immediate Release Tablets 2Health News:New Drug Application Submitted to FDA for Investigational Analgesic Tapentadol Immediate Release Tablets 3Health News:New Drug Application Submitted to FDA for Investigational Analgesic Tapentadol Immediate Release Tablets 4Health News:Engineering chimeric polypeptides to illuminate cellular redox states 2Health News:Co-Pays Contribute to Drop in Preventive Care 2Health News:Co-Pays Contribute to Drop in Preventive Care 3Health News:Advanced Therapy Aids Stroke Patients 2Health News:Advanced Therapy Aids Stroke Patients 3Health News:Genetic difference predicts antidepressant response 2Health News:EPA Awards $154,848 Grant to Canton Local School District for Clean School Bus Project 2
Karlin XL Magnum Cup Curettes, extra long (XL) curettes, black handles, lightweight, length 13 1/4" (33.7 cm), handle length 8 1/2" (21 cm), handle diameter 1 1/4" (32 cm)....
XL Cervical Curette comes with a bayonet design and satin black handles having instrument length 9.5" (24 cm), working distance4.1" (10.4 cm) and handle width 0.6" (1.5 cm)....
Caspar Curette, 250 mm, 10"....
Bone Curette, 160 mm...
Medicine Products: